242 related articles for article (PubMed ID: 19723148)
1. The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas.
Rizvi SM; Goodwill J; Lim E; Yap YK; Wells AU; Hansell DM; Davis P; Selim AG; Goldstraw P; Nicholson AG
Histopathology; 2009 Sep; 55(3):332-7. PubMed ID: 19723148
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of neural-cadherin in pulmonary epithelial tumours.
Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
[TBL] [Abstract][Full Text] [Related]
3. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms.
Ruffini E; Bongiovanni M; Cavallo A; Filosso PL; Giobbe R; Mancuso M; Molinatti M; Oliaro A
Eur J Cardiothorac Surg; 2004 Jul; 26(1):165-72. PubMed ID: 15200997
[TBL] [Abstract][Full Text] [Related]
4. Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours.
Kasprzak A; Olejniczak K; Przybyszewska W; Zabel M
Folia Morphol (Warsz); 2007 Aug; 66(3):159-66. PubMed ID: 17985312
[TBL] [Abstract][Full Text] [Related]
5. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
7. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity.
Gorshtein A; Gross DJ; Barak D; Strenov Y; Refaeli Y; Shimon I; Grozinsky-Glasberg S
Cancer; 2012 Feb; 118(3):612-9. PubMed ID: 21751183
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine structures in normal and diseased human lung.
Mosca L; Ceresoli A; Anzanello E; Mauri F; Mariscotti C; Timossi R; Barbareschi M; Mezzetti M
Appl Pathol; 1986; 4(3):147-61. PubMed ID: 3036186
[TBL] [Abstract][Full Text] [Related]
9. LKB1 protein expression in neuroendocrine tumors of the lung.
Amin RM; Hiroshima K; Iyoda A; Hoshi K; Honma K; Kuroki M; Kokubo T; Fujisawa T; Miyagi Y; Nakatani Y
Pathol Int; 2008 Feb; 58(2):84-8. PubMed ID: 18199157
[TBL] [Abstract][Full Text] [Related]
10. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
[TBL] [Abstract][Full Text] [Related]
11. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells.
Chetty R
Pathology; 2000 Aug; 32(3):209-12. PubMed ID: 10968398
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine tumours in the respiratory tract.
de Bruïne AP; Bosman FT
Acta Histochem Suppl; 1990; 38():99-105. PubMed ID: 1964229
[No Abstract] [Full Text] [Related]
13. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.
Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC
J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337
[TBL] [Abstract][Full Text] [Related]
14. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers.
Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
[TBL] [Abstract][Full Text] [Related]
15. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
[TBL] [Abstract][Full Text] [Related]
16. Small neuroendocrine lesions in intrathoracic lymph nodes of patients with primary lung adenocarcinoma: real metastasis?
Li F; Wang X; Xu H; Roggli VL
Am J Surg Pathol; 2010 Nov; 34(11):1701-7. PubMed ID: 20871390
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine neoplasms of the lung. A clinicopathologic update.
Warren WH; Faber LP; Gould VE
J Thorac Cardiovasc Surg; 1989 Sep; 98(3):321-32. PubMed ID: 2549306
[TBL] [Abstract][Full Text] [Related]
18. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with multiple synchronous carcinoid tumors.
Montoro Zulueta FJ; Martínez Prieto M; Verdugo Cartas MI; Esteban Rodriguez I; Hernández Muñiz S
Arch Bronconeumol; 2012 Dec; 48(12):472-5. PubMed ID: 22386668
[TBL] [Abstract][Full Text] [Related]
19. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
20. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G
J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
